Home › Trial NCT01772797
Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung Cancer
- Trial IDNCT01772797
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorNovartis Pharmaceuticals
- Enrollment22
- Start date2013-06
- ConditionsAnaplastic Lymphoma Kinase (ALK) · Non-small Cell Lung Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.